Annual Congress Stockholm 2007

Saturday, 15.09.2007
Sunday, 16.09.2007
Monday, 17.09.2007
Tuesday, 18.09.2007
Wednesday, 19.09.2007

Citations should be made in the following way: Authors. Title. Eur Respir J 2007; 30: Suppl. 51, abstract number.

Material from 2007:

4066 Abstracts
635 Slide presentations
310 Webcasts
98 Handouts
1992 e-posters
310 Multimedia files

Material from 2007: Show

Treatment and care of COPD

Oral Presentation
Chairs: N. Roche (Paris, France), L. Chovan (Bratislava, Slovakia)

Download all media

COPD early supported discharge in a remote and rural district general hospital H. Coles, C. Hope, M. Gall, P. Murphie, C. Hunter-Rowe, P. Rafferty, J. Gysin, S. Little (Dumfries, United Kingdom)
Determinants of discharge treatment after hospitalization for an acute exacerbation of COPD N. Roche, D. Soussan, M. Zureik, D. Perrotin, F. Neukirch (Paris, France)
Efficacy of moxifloxacin for treatment of bronchial colonisation in COPD patients: a randomised, double-blind, placebo-controlled study M. Miravitlles, E. Monsó, S. Vilà, C. de la Roza, A. Marín, R. Hervas, C. Esquinas, M. García, J. Morera, A. Torres (Barcelona, Badalona, Spain)
Frequency of acute flow and volume responses to bronchodilator administration in patients with COPD B. Celli, M. Decramer, D. Tashkin, C. Cassino, D. Burkhart, S. Kesten (Boston, MA, Los Angeles, CA, Ridgefield, CT, United States Of America; Leuven, Belgium)
Pulmonary vasodilator therapy in severe COPD: a double-blind, placebo-controlled trial D. Stolz, H. Rasch, A. Linka, M. Di Valentino, A. Meyer, K. Bögl, K. Bruppacher, M. Brutsche, M. Tamm (Basel, Winthertur, Baden, Switzerland)
Change in clinical COPD questionnaire (CCQ) symptoms domain score and FEV₁predict treatment failure during hospitalisation due to COPD exacerbations J. W. H. Kocks, S. M. Uil, H. Kerstjens, T. van der Molen, J. W. K. van den Berg (Groningen, Zwolle, Netherlands)
Medication use in COPD: systematic review and meta-analysis R. Halbert, J. Natoli, M. Lopez (Los Angeles, CA, Beverly Hills, CA, United States Of America; Montevideo, Uruguay)
A therapeutic arteriovenous fistula not only improves exercise tolerance, but also BODE index in patients with severe COPD J. Faul, B. Celli, J. Galindo, R. Posadas-Valay, G. Elizondo-Riojas, A. Martinez, M. Meysman, M. Noppen, N. Morrell, P. Sivasothy, H. Sievert, P. Kardos, R. Brenneman (Dublin, Ireland; Boston, MA, San Clemente, CA, United States Of America; Nuevo Leon, Me